BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Rhabdomyosarcoma AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
4 results:

  • 1. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
    Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
    Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological and Molecular Characteristics of Intraosseous rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
    Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
    Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
    Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y
    Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
    Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.